应用人工神经网络预测药物的生物药剂学分类

陈敏燕 金芝贵 吴飞华 梁文权

中国药学杂志 ›› 2010, Vol. 45 ›› Issue (9) : 669-676.

PDF(1098 KB)
PDF(1098 KB)
中国药学杂志 ›› 2010, Vol. 45 ›› Issue (9) : 669-676.
论著

应用人工神经网络预测药物的生物药剂学分类

  • 陈敏燕1,金芝贵1,吴飞华1,梁文权2*
作者信息 +

Study on the Prediction of Biopharmaceutics Classification System

  • CHEN Min-yan1, JIN Zhi-gui1,WU Fei-hua1,LIANG Wen-quan2*
Author information +
文章历史 +

引用本文

导出引用
陈敏燕 金芝贵 吴飞华 梁文权. 应用人工神经网络预测药物的生物药剂学分类[J]. 中国药学杂志, 2010, 45(9): 669-676
CHEN Min-yn;JIN Zhi-gui;WU Fei-hu;LING Wen-qun. Study on the Prediction of Biopharmaceutics Classification System[J]. Chinese Pharmaceutical Journal, 2010, 45(9): 669-676

参考文献


[1] LIANG W Q. Biopharmaceutics and pharmacokinetics(生物药剂学与药物动力学)[M]. 3rd. ed. Beijing: People′s Medical Publishing House,2007:49-52.
[2] OLESZEK-KUDLAK S, GRABDA M, SHIBATA E, et al. Application of the conductor-like screening model for real solvents for prediction of the aqueous solubility of chlorobenzenes depending on temperature and salinity[J]. Environ Toxicol Chem, 2005, 24 (6): 1368-1375.
[3] HUUSKONEN J, LIVINGSTONE D J, MANALLACK D T. Prediction of drug solubility from molecular structure using a drug-like training set[J]. SAR QSAR Environ Res, 2008,19(3-4): 191-212.
[4] PALMER D S, O′BOYLE N M, GLEN R C,et al. Random forest models to predict aqueous solubility[J]. J Chem Inf Model,2007,47(1):150-158.
[5] ERTL P, ROHDE B, SELZER P. Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties[J]. J Med Chem, 2000,43(20):3714- 3717.
[6] FALLER B, ERTL P. Computational approaches to determine drug solubility [J]. Adv Drug Deliv Rev,2007,59(7):533-545.
[7] ZHANG H Z, ANDO H Y,CHEN L N, et al. On-the-fly selection of a training set for aqueous solubility prediction [J]. Mol Pharm, 2007, 4 (4): 489-497.
[8] CLARK D. Rapid calculation of polar molecular surface area and its application to the prediction of transport phenomena. 1. Prediction of intestinal absorption[J]. J Pharm Sci, 1999, 88 (8): 807-814.
[9] PALM K, STENBERG P, LUTHMAN K, et al. Polar molecular surface properties predict and the intestinal absorption of drugs in humans[J]. Pharm Res, 1997,14 (5): 568-571.
[10] PALM K, LUTHMAN K, UNGELL A L, et al. Correlation of drug absorption with molecular surface properties[J]. J Pharm Sci, 1996, 85 (1):32-39.
[11] ABRAHAM M H, LE J. The correlation and prediction of the solubility of compounds in water using an amended solvation energy relationship[J]. J Pharm Sci, 1999, 88 (9): 868-880.
[12] AVDEEF A, BERGER C M, BROWNELL C. pH-metric solubility 2: correlation between the acid-base titration and the saturation shake-flask solubility-pH methods [J]. Pharm Res, 2000, 17(10): 85-89.
[13] AVDEEF A. Absorption and Drug Development[M]. New York: Wiley-Intersience, 2003.
[14] KRISTL A, PECAR S. Hydrolipophilic anomalies of some guanine derivatives[J]. Eur J Med Chem, 1997, 32(1): 3-8.
[15] FALLER B, GRIMM H P, LOEUILLET-RITZLER F,et al. Highthroughput lipophilicity measurement with immobilized artificial membranes[J]. J Med Chem, 2005, 48 (7): 2571-2576.
[16] TESTA B,VAN DE WATERBEEMD H,FOLKERS G,et al. Pharmacokinetic Optimization in Drug Research: Biological, Physicochemical and Computational Strategies[M]. Switzerland: Verlag Helvetica Chimica Acta, 2001.
[17] BERGSTROEM C A, STRAFFORD M, LAZOROVA, et al. Absorption classification of oral drugs based on molecular surface properties[J]. J Med Chem, 2003, 46 (4): 558-570.
[18] AVDEEF A, BERGER C M. pH-metric solubility: 3. Dissolution titration template method for solubility determination[J]. Eur J Pharm Sci, 2001, 14 (4): 281-291.
[19] AVDEEF A. Physicochemical profiling (solubility, permeability and charge state)[J]. Curr Top Med Chem, 2001,1(14):277-351.
[20] CARON G, STEYAERT G, PAGLIARA A, et al. Structure-lipophilicity relationships of neutral and protonated b-blockers. Part 1. Intra and inter- molecular effects in isotropic solvent systems[J]. Helv Chim Acta, 1999, 82 (8): 1211-1222.
[21] SLATER B, MCCORMACK A, AVDEEF A, et al. pH-Metric log P. 4. Com- parison of partition coefficients determined by HPLC and potentiometric methods to literature values [J]. J Pharm Sci, 1994, 83(9): 1280-1283.
[22] KANSY M, FISCHER H, KRATZAT K, et al. High-throughput artificial membrane permeability studies in early lead discovery and development. In: Testa, B., van de Waterbeemd, H., Folkers, G., Guy, R. (Eds.), Pharmacokinetic Optimization in Drug Research[M]. Verlag Helvetica Chimica Acta: Zürich and Wiley - VCH: Weinheim, 2001.
[23] WINIWARTER S, BONHAM N M, AX F, et al. Correlation of human jejunal permeability (in vivo) of drugs with experimentally and theoretically derived parameters, a multivariate data analysis approach[J]. J Med Chem, 1998, 41 (25): 4939-4949.
[24] JAIN N, YALKOWSKY S H. Estimation of the aqueous solubility I: application to organic nonelectrolytes[J]. J Pharm Sci, 2001, 90 (6): 234-252.
[25] LOMBARDO F, SHALAEVA M Y, TUPPER K A, et al. ElogPoct: a tool for lipophilicity determination in drug discovery[J]. J Med Chem, 2000, 43 (15): 2922-2928.
[26] PONEC M, KEMPENAAR J, SHROOT B, et al. Glucocorticoids: binding affinity and lipophilicity[J]. J Pharm Sci, 1986, 75 (10): 973-975.
[27] WIEDMANN T S, LIANG W, KAMEL L. Solubilization of drugs by physiological mixtures of bile salts[J]. Pharm Res, 2002, 19 (8): 1203-1208.
[28] GLOMME A, MAERZ J, DRESSMAN J B. Comparison of a miniaturized shake-flask solubility method with automated potentiometric acid/base titrations and calculated solubilities[J]. J Pharm Sci, 2005, 94 (7): 1-16.
[29] Thomson P D R. Physicians′ Desk Reference[M]. 59th ed. Montvale, NJ: Thomson Healthcare, Inc, 2005.
[30] HARDMAN J G, LIMBIRD L E, GILMAN A G,et al. Pharmacokinetic Data Goodman & Gilman′s The Pharmacological Basis of Therapeutics[M].10th ed; New York: McGraw-Hill, 2001.
[31] SIETSEMA W K. The absolute oral bioavailability of selected drugs [J].Int J Clin Pharmacol Ther Toxicol, 1989, 27 (4): 179-211.
[32] DRESSMAN J B, THELEN K, JANTRATID E. Towards quantitative prediction of oral drug absorption[J]. Clin Pharmacokinet, 2008, 47(10):655-667.
[33] HAMILTON H W, STEINBAUGH B A, STEWART B H, et al. Evaluation of physicochemical parameters important to the oral bioavailability of peptide-like compounds: implications for the synthesis of renin inhibitors[J]. J Med Chem, 1995, 38 (9): 1446-1455.
[34] HOU T, WANG J, LI Y. ADME evaluation in drug discovery. 8. The prediction of human intestinal absorption by a support vector machine[J]. J Chem Inf Model, 2007,47(6):2408-2415.
[35] KELDENICH J. Measurement and prediction of oral absorption[J]. Chem Biodivers, 2009,6(11):2000-2013.
[36] PALM K, LUTHMAN K, UNGELL A L, et al. Correlation of drug absorption with molecular surface properties[J]. J Pharm Sci, 1996, 85 (1): 32-39.
[37] LINDENBERG M, KOPP S, DRESSMAN J B. Classification of orally administered drugs on the world health organization model list of essential medicines according to the biopharmaceutics classification system[J]. Eur J Pharm Biopharm, 2004, 58 (2): 265-278.
[38] KHANDELWAL A, BAHADDURI P M, CHENG C, et al. Computational models to assign biopharmaceutics drug disposition classification from molecular structure[J]. Pharm Res, 2007, 24 (12): 2249-2262.
[39] Essential Medicines: WHO Model List[J/OL],2005.http://whqlibdoc.who.int/ HQ/2005/a87017_eng.pdf
[40] WU C H, BENET L Z. Predicting drug disposition via application of BCS: transport/absorption/elimination interplay and development of a biopharma- ceutics drug disposition classification system[J]. Pharm Res, 2005, 22 (1): 11-23.
[41] DRESSMAN B. Proposal to waive in vivo bioequivalence requirements for the WHO model list of essential medicines immediate release,solid oral dosage forms[K].World health organization organisation mondiale de la sante. Working Document QAS/04.109/Rev.1.
PDF(1098 KB)

Accesses

Citation

Detail

段落导航
相关文章

/